ID   MAGA2_HUMAN             Reviewed;         314 AA.
AC   P43356; A8K328; Q32NC6;
DT   01-NOV-1995, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1995, sequence version 1.
DT   15-MAR-2017, entry version 147.
DE   RecName: Full=Melanoma-associated antigen 2;
DE   AltName: Full=Cancer/testis antigen 1.2;
DE            Short=CT1.2;
DE   AltName: Full=MAGE-2 antigen;
GN   Name=MAGEA2; Synonyms=MAGE2, MAGEA2A;
GN   and
GN   Name=MAGEA2B; Synonyms=MAGE2, MAGEA2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=8276455; DOI=10.1007/BF00188615;
RA   De Smet C., Lurquin C., van der Bruggen P., De Plaen E., Brasseur F.,
RA   Boon T.;
RT   "Sequence and expression pattern of the human MAGE2 gene.";
RL   Immunogenetics 39:121-129(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=10854409; DOI=10.1101/gr.10.6.758;
RA   Mallon A.-M., Platzer M., Bate R., Gloeckner G., Botcherby M.R.M.,
RA   Nordsiek G., Strivens M.A., Kioschis P., Dangel A., Cunningham D.,
RA   Straw R.N.A., Weston P., Gilbert M., Fernando S., Goodall K.,
RA   Hunter G., Greystrong J.S., Clarke D., Kimberley C., Goerdes M.,
RA   Blechschmidt K., Rump A., Hinzmann B., Mundy C.R., Miller W.,
RA   Poustka A., Herman G.E., Rhodes M., Denny P., Rosenthal A.,
RA   Brown S.D.M.;
RT   "Comparative genome sequence analysis of the Bpa/Str region in mouse
RT   and man.";
RL   Genome Res. 10:758-775(2000).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15772651; DOI=10.1038/nature03440;
RA   Ross M.T., Grafham D.V., Coffey A.J., Scherer S., McLay K., Muzny D.,
RA   Platzer M., Howell G.R., Burrows C., Bird C.P., Frankish A.,
RA   Lovell F.L., Howe K.L., Ashurst J.L., Fulton R.S., Sudbrak R., Wen G.,
RA   Jones M.C., Hurles M.E., Andrews T.D., Scott C.E., Searle S.,
RA   Ramser J., Whittaker A., Deadman R., Carter N.P., Hunt S.E., Chen R.,
RA   Cree A., Gunaratne P., Havlak P., Hodgson A., Metzker M.L.,
RA   Richards S., Scott G., Steffen D., Sodergren E., Wheeler D.A.,
RA   Worley K.C., Ainscough R., Ambrose K.D., Ansari-Lari M.A., Aradhya S.,
RA   Ashwell R.I., Babbage A.K., Bagguley C.L., Ballabio A., Banerjee R.,
RA   Barker G.E., Barlow K.F., Barrett I.P., Bates K.N., Beare D.M.,
RA   Beasley H., Beasley O., Beck A., Bethel G., Blechschmidt K., Brady N.,
RA   Bray-Allen S., Bridgeman A.M., Brown A.J., Brown M.J., Bonnin D.,
RA   Bruford E.A., Buhay C., Burch P., Burford D., Burgess J., Burrill W.,
RA   Burton J., Bye J.M., Carder C., Carrel L., Chako J., Chapman J.C.,
RA   Chavez D., Chen E., Chen G., Chen Y., Chen Z., Chinault C.,
RA   Ciccodicola A., Clark S.Y., Clarke G., Clee C.M., Clegg S.,
RA   Clerc-Blankenburg K., Clifford K., Cobley V., Cole C.G., Conquer J.S.,
RA   Corby N., Connor R.E., David R., Davies J., Davis C., Davis J.,
RA   Delgado O., Deshazo D., Dhami P., Ding Y., Dinh H., Dodsworth S.,
RA   Draper H., Dugan-Rocha S., Dunham A., Dunn M., Durbin K.J., Dutta I.,
RA   Eades T., Ellwood M., Emery-Cohen A., Errington H., Evans K.L.,
RA   Faulkner L., Francis F., Frankland J., Fraser A.E., Galgoczy P.,
RA   Gilbert J., Gill R., Gloeckner G., Gregory S.G., Gribble S.,
RA   Griffiths C., Grocock R., Gu Y., Gwilliam R., Hamilton C., Hart E.A.,
RA   Hawes A., Heath P.D., Heitmann K., Hennig S., Hernandez J.,
RA   Hinzmann B., Ho S., Hoffs M., Howden P.J., Huckle E.J., Hume J.,
RA   Hunt P.J., Hunt A.R., Isherwood J., Jacob L., Johnson D., Jones S.,
RA   de Jong P.J., Joseph S.S., Keenan S., Kelly S., Kershaw J.K., Khan Z.,
RA   Kioschis P., Klages S., Knights A.J., Kosiura A., Kovar-Smith C.,
RA   Laird G.K., Langford C., Lawlor S., Leversha M., Lewis L., Liu W.,
RA   Lloyd C., Lloyd D.M., Loulseged H., Loveland J.E., Lovell J.D.,
RA   Lozado R., Lu J., Lyne R., Ma J., Maheshwari M., Matthews L.H.,
RA   McDowall J., McLaren S., McMurray A., Meidl P., Meitinger T.,
RA   Milne S., Miner G., Mistry S.L., Morgan M., Morris S., Mueller I.,
RA   Mullikin J.C., Nguyen N., Nordsiek G., Nyakatura G., O'dell C.N.,
RA   Okwuonu G., Palmer S., Pandian R., Parker D., Parrish J.,
RA   Pasternak S., Patel D., Pearce A.V., Pearson D.M., Pelan S.E.,
RA   Perez L., Porter K.M., Ramsey Y., Reichwald K., Rhodes S.,
RA   Ridler K.A., Schlessinger D., Schueler M.G., Sehra H.K.,
RA   Shaw-Smith C., Shen H., Sheridan E.M., Shownkeen R., Skuce C.D.,
RA   Smith M.L., Sotheran E.C., Steingruber H.E., Steward C.A., Storey R.,
RA   Swann R.M., Swarbreck D., Tabor P.E., Taudien S., Taylor T.,
RA   Teague B., Thomas K., Thorpe A., Timms K., Tracey A., Trevanion S.,
RA   Tromans A.C., d'Urso M., Verduzco D., Villasana D., Waldron L.,
RA   Wall M., Wang Q., Warren J., Warry G.L., Wei X., West A.,
RA   Whitehead S.L., Whiteley M.N., Wilkinson J.E., Willey D.L.,
RA   Williams G., Williams L., Williamson A., Williamson H., Wilming L.,
RA   Woodmansey R.L., Wray P.W., Yen J., Zhang J., Zhou J., Zoghbi H.,
RA   Zorilla S., Buck D., Reinhardt R., Poustka A., Rosenthal A.,
RA   Lehrach H., Meindl A., Minx P.J., Hillier L.W., Willard H.F.,
RA   Wilson R.K., Waterston R.H., Rice C.M., Vaudin M., Coulson A.,
RA   Nelson D.L., Weinstock G., Sulston J.E., Durbin R.M., Hubbard T.,
RA   Gibbs R.A., Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence of the human X chromosome.";
RL   Nature 434:325-337(2005).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Skin;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   MUTAGENESIS.
RC   TISSUE=Blood;
RX   PubMed=8113684; DOI=10.1084/jem.179.3.921;
RA   Gaugler B., van den Eynde B., van der Bruggen P., Romero P.,
RA   Gaforio J.J., De Plaen E., Lethe B.G., Brasseur F., Boon T.;
RT   "Human gene MAGE-3 codes for an antigen recognized on a melanoma by
RT   autologous cytolytic T lymphocytes.";
RL   J. Exp. Med. 179:921-930(1994).
RN   [8]
RP   FUNCTION, SUBCELLULAR LOCATION, AND INTERACTION WITH TP53 AND HDAC3.
RX   PubMed=16847267; DOI=10.1073/pnas.0510834103;
RA   Monte M., Simonatto M., Peche L.Y., Bublik D.R., Gobessi S.,
RA   Pierotti M.A., Rodolfo M., Schneider C.;
RT   "MAGE-A tumor antigens target p53 transactivation function through
RT   histone deacetylase recruitment and confer resistance to
RT   chemotherapeutic agents.";
RL   Proc. Natl. Acad. Sci. U.S.A. 103:11160-11165(2006).
RN   [9]
RP   FUNCTION.
RX   PubMed=17942928; DOI=10.1158/0008-5472.CAN-07-1478;
RA   Yang B., O'Herrin S.M., Wu J., Reagan-Shaw S., Ma Y., Bhat K.M.,
RA   Gravekamp C., Setaluri V., Peters N., Hoffmann F.M., Peng H.,
RA   Ivanov A.V., Simpson A.J., Longley B.J.;
RT   "MAGE-A, mMage-b, and MAGE-C proteins form complexes with KAP1 and
RT   suppress p53-dependent apoptosis in MAGE-positive cell lines.";
RL   Cancer Res. 67:9954-9962(2007).
RN   [10]
RP   FUNCTION, AND INTERACTION WITH TRIM28 AND UBE2H.
RX   PubMed=20864041; DOI=10.1016/j.molcel.2010.08.029;
RA   Doyle J.M., Gao J., Wang J., Yang M., Potts P.R.;
RT   "MAGE-RING protein complexes comprise a family of E3 ubiquitin
RT   ligases.";
RL   Mol. Cell 39:963-974(2010).
RN   [11]
RP   FUNCTION, SUBCELLULAR LOCATION, AND INTERACTION WITH PML.
RX   PubMed=22117195; DOI=10.1038/cdd.2011.173;
RA   Peche L.Y., Scolz M., Ladelfa M.F., Monte M., Schneider C.;
RT   "MageA2 restrains cellular senescence by targeting the function of
RT   PMLIV/p53 axis at the PML-NBs.";
RL   Cell Death Differ. 19:926-936(2012).
CC   -!- FUNCTION: Reduces p53/TP53 transactivation function through
CC       recruitment of HDAC3 to p53/TP53 transcription sites. Also
CC       represses p73/TP73 activity. Proposed to enhance ubiquitin ligase
CC       activity of RING-type zinc finger-containing E3 ubiquitin-protein
CC       ligases. In vitro enhances ubiquitin ligase activity of TRIM28 and
CC       stimulates p53/TP53 ubiquitination by TRIM28 potentially in
CC       presence of Ubl-conjugating enzyme UBE2H. Proposed to act through
CC       recruitment and/or stabilization of the Ubl-conjugating enzyme
CC       (E2) at the E3:substrate complex. May play a role in embryonal
CC       development and tumor transformation or aspects of tumor
CC       progression. In vitro promotes cell viability in melanoma cell
CC       lines. Antigen recognized on a melanoma by autologous cytolytic T-
CC       lymphocytes. Negatively regulates acetylation and sumoylation of
CC       PML and represses PML-induced p53/TP53 acetylation and activation.
CC       {ECO:0000269|PubMed:16847267, ECO:0000269|PubMed:17942928,
CC       ECO:0000269|PubMed:20864041, ECO:0000269|PubMed:22117195}.
CC   -!- SUBUNIT: Interacts with TRIM28 and UBE2H. Interacts with HDAC3.
CC       Interacts with PML (isoform PML-1, isoform PML-2, isoform PML-3,
CC       isoform PML-4 and isoform PML-5). {ECO:0000269|PubMed:16847267,
CC       ECO:0000269|PubMed:20864041, ECO:0000269|PubMed:22117195}.
CC   -!- INTERACTION:
CC       Q08AH1:ACSM1; NbExp=4; IntAct=EBI-5650739, EBI-2818055;
CC       O15379:HDAC3; NbExp=4; IntAct=EBI-5650739, EBI-607682;
CC       O95983-2:MBD3; NbExp=4; IntAct=EBI-5650739, EBI-11978579;
CC       Q7Z4N8:P4HA3; NbExp=4; IntAct=EBI-5650739, EBI-10181968;
CC       Q99719:SEPT5; NbExp=4; IntAct=EBI-5650739, EBI-373345;
CC       Q96KP6:TNIP3; NbExp=4; IntAct=EBI-5650739, EBI-2509913;
CC       P04637:TP53; NbExp=6; IntAct=EBI-5650739, EBI-366083;
CC       Q13263:TRIM28; NbExp=6; IntAct=EBI-5650739, EBI-78139;
CC       P62256:UBE2H; NbExp=2; IntAct=EBI-5650739, EBI-2129909;
CC       Q96HA8:WDYHV1; NbExp=4; IntAct=EBI-5650739, EBI-741158;
CC   -!- SUBCELLULAR LOCATION: Nucleus. Nucleus, PML body.
CC   -!- TISSUE SPECIFICITY: Expressed in many tumors of several types,
CC       such as melanoma, head and neck squamous cell carcinoma, lung
CC       carcinoma and breast carcinoma, but not in normal tissues except
CC       for testes.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; L18920; AAA17729.1; -; Genomic_DNA.
DR   EMBL; AK290443; BAF83132.1; -; mRNA.
DR   EMBL; U82671; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471169; EAW99429.1; -; Genomic_DNA.
DR   EMBL; BC108720; AAI08721.1; -; mRNA.
DR   EMBL; BC112158; AAI12159.1; -; mRNA.
DR   EMBL; BC112160; AAI12161.1; -; mRNA.
DR   CCDS; CCDS76046.1; -.
DR   CCDS; CCDS76049.1; -.
DR   PIR; I68889; I68889.
DR   RefSeq; NP_001269430.1; NM_001282501.1.
DR   RefSeq; NP_001269431.1; NM_001282502.1.
DR   RefSeq; NP_001269433.1; NM_001282504.1.
DR   RefSeq; NP_001269434.1; NM_001282505.1.
DR   RefSeq; NP_001308329.1; NM_001321400.1.
DR   RefSeq; NP_001308330.1; NM_001321401.1.
DR   RefSeq; NP_001308331.1; NM_001321402.1.
DR   RefSeq; NP_001308332.1; NM_001321403.1.
DR   RefSeq; NP_001308333.1; NM_001321404.1.
DR   RefSeq; NP_005352.1; NM_005361.3.
DR   RefSeq; NP_705692.1; NM_153488.4.
DR   RefSeq; NP_786884.1; NM_175742.2.
DR   RefSeq; NP_786885.1; NM_175743.2.
DR   RefSeq; XP_016884895.1; XM_017029406.1.
DR   RefSeq; XP_016885008.1; XM_017029519.1.
DR   UniGene; Hs.534597; -.
DR   UniGene; Hs.713061; -.
DR   UniGene; Hs.736992; -.
DR   ProteinModelPortal; P43356; -.
DR   SMR; P43356; -.
DR   BioGrid; 110275; 6.
DR   BioGrid; 129334; 10.
DR   DIP; DIP-61231N; -.
DR   IntAct; P43356; 25.
DR   STRING; 9606.ENSP00000359307; -.
DR   iPTMnet; P43356; -.
DR   PhosphoSitePlus; P43356; -.
DR   BioMuta; MAGEA2; -.
DR   DMDM; 1170856; -.
DR   MaxQB; P43356; -.
DR   PaxDb; P43356; -.
DR   PeptideAtlas; P43356; -.
DR   PRIDE; P43356; -.
DR   DNASU; 266740; -.
DR   DNASU; 4101; -.
DR   Ensembl; ENST00000331220; ENSP00000333487; ENSG00000183305.
DR   Ensembl; ENST00000370293; ENSP00000359316; ENSG00000183305.
DR   Ensembl; ENST00000595583; ENSP00000470872; ENSG00000268606.
DR   Ensembl; ENST00000598543; ENSP00000469919; ENSG00000268606.
DR   Ensembl; ENST00000611557; ENSP00000480738; ENSG00000268606.
DR   Ensembl; ENST00000611674; ENSP00000480491; ENSG00000268606.
DR   Ensembl; ENST00000620710; ENSP00000484290; ENSG00000268606.
DR   Ensembl; ENST00000623438; ENSP00000485391; ENSG00000268606.
DR   Ensembl; ENST00000623806; ENSP00000485541; ENSG00000268606.
DR   GeneID; 266740; -.
DR   GeneID; 4101; -.
DR   KEGG; hsa:266740; -.
DR   KEGG; hsa:4101; -.
DR   UCSC; uc004fgg.3; human.
DR   CTD; 266740; -.
DR   CTD; 4101; -.
DR   DisGeNET; 266740; -.
DR   DisGeNET; 4101; -.
DR   GeneCards; MAGEA2; -.
DR   GeneCards; MAGEA2B; -.
DR   HGNC; HGNC:6800; MAGEA2.
DR   HGNC; HGNC:19340; MAGEA2B.
DR   MIM; 300173; gene.
DR   MIM; 300549; gene.
DR   neXtProt; NX_P43356; -.
DR   OpenTargets; ENSG00000183305; -.
DR   PharmGKB; PA30546; -.
DR   eggNOG; KOG4562; Eukaryota.
DR   eggNOG; ENOG4111S70; LUCA.
DR   GeneTree; ENSGT00760000118824; -.
DR   HOGENOM; HOG000231161; -.
DR   HOVERGEN; HBG006315; -.
DR   InParanoid; P43356; -.
DR   OMA; EPHISYP; -.
DR   OrthoDB; EOG091G0TJ0; -.
DR   PhylomeDB; P43356; -.
DR   TreeFam; TF328505; -.
DR   GeneWiki; MAGEA2; -.
DR   PRO; PR:P43356; -.
DR   Proteomes; UP000005640; Chromosome X.
DR   Bgee; ENSG00000183305; -.
DR   CleanEx; HS_MAGEA2; -.
DR   ExpressionAtlas; P43356; baseline and differential.
DR   Genevisible; P43356; HS.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0016605; C:PML body; IDA:UniProtKB.
DR   GO; GO:0042826; F:histone deacetylase binding; IDA:UniProtKB.
DR   GO; GO:0070491; F:repressing transcription factor binding; IDA:UniProtKB.
DR   GO; GO:0031625; F:ubiquitin protein ligase binding; IDA:UniProtKB.
DR   GO; GO:0044257; P:cellular protein catabolic process; IMP:UniProtKB.
DR   GO; GO:0090398; P:cellular senescence; IDA:UniProtKB.
DR   GO; GO:1901984; P:negative regulation of protein acetylation; IDA:UniProtKB.
DR   GO; GO:0033234; P:negative regulation of protein sumoylation; IDA:UniProtKB.
DR   GO; GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB.
DR   GO; GO:0051443; P:positive regulation of ubiquitin-protein transferase activity; IMP:UniProtKB.
DR   GO; GO:0072331; P:signal transduction by p53 class mediator; IDA:UniProtKB.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW.
DR   InterPro; IPR021072; MAGE_N.
DR   InterPro; IPR002190; MHD_dom.
DR   Pfam; PF01454; MAGE; 2.
DR   Pfam; PF12440; MAGE_N; 1.
DR   SMART; SM01373; MAGE; 1.
DR   SMART; SM01392; MAGE_N; 1.
DR   PROSITE; PS50838; MAGE; 1.
PE   1: Evidence at protein level;
KW   Complete proteome; Nucleus; Phosphoprotein; Reference proteome;
KW   Transcription; Transcription regulation; Tumor antigen;
KW   Ubl conjugation pathway.
FT   CHAIN         1    314       Melanoma-associated antigen 2.
FT                                /FTId=PRO_0000156702.
FT   DOMAIN      109    308       MAGE. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00127}.
FT   COMPBIAS     40     43       Poly-Ser.
FT   MOD_RES      64     64       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P43355}.
FT   MUTAGEN     170    170       V->D: Improves ability to bind to HLA-A1.
FT                                {ECO:0000269|PubMed:8113684}.
SQ   SEQUENCE   314 AA;  35055 MW;  844F16335A2BECE7 CRC64;
     MPLEQRSQHC KPEEGLEARG EALGLVGAQA PATEEQQTAS SSSTLVEVTL GEVPAADSPS
     PPHSPQGASS FSTTINYTLW RQSDEGSSNQ EEEGPRMFPD LESEFQAAIS RKMVELVHFL
     LLKYRAREPV TKAEMLESVL RNCQDFFPVI FSKASEYLQL VFGIEVVEVV PISHLYILVT
     CLGLSYDGLL GDNQVMPKTG LLIIVLAIIA IEGDCAPEEK IWEELSMLEV FEGREDSVFA
     HPRKLLMQDL VQENYLEYRQ VPGSDPACYE FLWGPRALIE TSYVKVLHHT LKIGGEPHIS
     YPPLHERALR EGEE
//
